2007, 2008, 2009
In collaboration with an anonymous funder, Cure Alzheimer’s Fund is supporting development of a facility to measure the concentration of Amyloid-beta in real time in the brain of living, behaving mouse models that develop features of AD. The model enables screening for drugs that lower Amyloid-beta directly in the brain in relatively high throughput.
Drug Discovery, Drug Screening Projects
David Holtzman, M.D.
David Holtzman, | 2022
Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021
Weiming Xia, | 2021
Stephen T.C. Wong, | 2021
Hermann Steller, | 2021
Doo Yeon Kim, Luisa Quinti, | 2021
Seiko Ikezu, Tsuneya Ikezu, | 2021
Ana Griciuc, | 2021